402 related articles for article (PubMed ID: 26577047)
21. [Treatment of cholestatic liver diseases with ursodeoxycholic acid].
Boberg KM; Schrumpf E
Tidsskr Nor Laegeforen; 1997 Sep; 117(23):3370-3. PubMed ID: 9411890
[TBL] [Abstract][Full Text] [Related]
22. Primary biliary cirrhosis in adults.
Momah N; Lindor KD
Expert Rev Gastroenterol Hepatol; 2014 May; 8(4):427-33. PubMed ID: 24580040
[TBL] [Abstract][Full Text] [Related]
23. Molecular mechanisms of ursodeoxycholic acid toxicity & side effects: ursodeoxycholic acid freezes regeneration & induces hibernation mode.
Kotb MA
Int J Mol Sci; 2012; 13(7):8882-8914. PubMed ID: 22942741
[TBL] [Abstract][Full Text] [Related]
24. Old and novel therapies for primary biliary cirrhosis.
Parés A
Semin Liver Dis; 2014 Aug; 34(3):341-51. PubMed ID: 25057957
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic advances for primary biliary cholangitis: the old and the new.
Wang L; Zhang FC; Zhang X
Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):615-21. PubMed ID: 26862931
[TBL] [Abstract][Full Text] [Related]
26. Serological markers for monitoring disease progression in noncirrhotic primary biliary cirrhosis on ursodeoxycholic acid therapy.
Färkkilä M; Rautiainen H; Kärkkäinen P; Karvonen AL; Nurmi H; Niemelä O
Liver Int; 2008 Jul; 28(6):787-97. PubMed ID: 18397236
[TBL] [Abstract][Full Text] [Related]
27. Novel Therapies on Primary Biliary Cirrhosis.
Czul F; Levy C
Clin Liver Dis; 2016 Feb; 20(1):113-30. PubMed ID: 26593294
[TBL] [Abstract][Full Text] [Related]
28. Primary biliary cirrhosis: overlaps with other autoimmune disorders.
Floreani A; Franceschet I; Cazzagon N
Semin Liver Dis; 2014 Aug; 34(3):352-60. PubMed ID: 25057958
[TBL] [Abstract][Full Text] [Related]
29. Advances in pharmacotherapy for primary biliary cirrhosis.
Mousa HS; Lleo A; Invernizzi P; Bowlus CL; Gershwin ME
Expert Opin Pharmacother; 2015 Apr; 16(5):633-43. PubMed ID: 25543678
[TBL] [Abstract][Full Text] [Related]
30. [Primary biliary cirrhosis].
Chon CY; Park JY
Korean J Hepatol; 2006 Sep; 12(3):364-72. PubMed ID: 16998288
[TBL] [Abstract][Full Text] [Related]
31. Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis.
Combes B; Emerson SS; Flye NL; Munoz SJ; Luketic VA; Mayo MJ; McCashland TM; Zetterman RK; Peters MG; Di Bisceglie AM; Benner KG; Kowdley KV; Carithers RL; Rosoff L; Garcia-Tsao G; Boyer JL; Boyer TD; Martinez EJ; Bass NM; Lake JR; Barnes DS; Bonacini M; Lindsay KL; Mills AS; Markin RS; Rubin R; West AB; Wheeler DE; Contos MJ; Hofmann AF
Hepatology; 2005 Nov; 42(5):1184-93. PubMed ID: 16250039
[TBL] [Abstract][Full Text] [Related]
32. Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection?
Hay JE
Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S9-17. PubMed ID: 9742489
[TBL] [Abstract][Full Text] [Related]
33. Guidelines for therapy of autoimmune liver disease.
Ishibashi H; Komori A; Shimoda S; Gershwin ME
Semin Liver Dis; 2007 May; 27(2):214-26. PubMed ID: 17520519
[TBL] [Abstract][Full Text] [Related]
34. Treatment of primary biliary cirrhosis.
Poupon R; Poupon RE
Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):615-28. PubMed ID: 10976018
[TBL] [Abstract][Full Text] [Related]
35. Diagnosis and management of primary biliary cirrhosis.
Ali AH; Carey EJ; Lindor KD
Expert Rev Clin Immunol; 2014 Dec; 10(12):1667-78. PubMed ID: 25382237
[TBL] [Abstract][Full Text] [Related]
36. Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis.
Rust C; Beuers U
Clin Rev Allergy Immunol; 2005 Apr; 28(2):135-45. PubMed ID: 15879619
[TBL] [Abstract][Full Text] [Related]
37. Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with primary biliary cirrhosis.
Corpechot C; Poujol-Robert A; Wendum D; Galotte M; Chrétien Y; Poupon RE; Poupon R
Liver Int; 2004 Jun; 24(3):187-93. PubMed ID: 15189267
[TBL] [Abstract][Full Text] [Related]
38. [Medical treatment of chronic cholestasis: ursodeoxycholic acid].
Linares Rodríguez A
Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():24-38. PubMed ID: 11968340
[No Abstract] [Full Text] [Related]
39. New Therapeutic Strategies for Primary Sclerosing Cholangitis.
Williamson KD; Chapman RW
Semin Liver Dis; 2016 Feb; 36(1):5-14. PubMed ID: 26870928
[TBL] [Abstract][Full Text] [Related]
40. Toward precision medicine in primary biliary cholangitis.
Carbone M; Ronca V; Bruno S; Invernizzi P; Mells GF
Dig Liver Dis; 2016 Aug; 48(8):843-50. PubMed ID: 27324985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]